Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes (Q44775968)

6 December 2017

Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes (English)

1 reference

6 December 2017

1 reference

Rita Basu

1

1 reference

PubMed ID

14982753

6 December 2017

W Frederick Schwenk

series ordinal

2

1 reference

PubMed ID

14982753

6 December 2017

Robert A Rizza

series ordinal

3

1 reference

6 December 2017

24 February 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

6 December 2017

1 reference

6 December 2017

287

1 reference

6 December 2017

1

1 reference

6 December 2017

E55-62

1 reference

Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans

6 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Quantifying gluconeogenesis during fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Contributions of gluconeogenesis to glucose production in the fasted state

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Quantitation of basal endogenous glucose production in Type II diabetes: importance of the volume of distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

High-pressure liquid chromatographic analysis of indocyanine green.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Determination of the enrichment of the hydrogen bound to carbon 5 of glucose on 2H2O administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00549.2003

10.1152/AJPENDO.00549.2003

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference

PubMed ID

14982753